Frédéric Delouvroy

536 total citations
5 papers, 210 citations indexed

About

Frédéric Delouvroy is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Frédéric Delouvroy has authored 5 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Frédéric Delouvroy's work include Hepatitis C virus research (5 papers), Hepatitis B Virus Studies (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Frédéric Delouvroy is often cited by papers focused on Hepatitis C virus research (5 papers), Hepatitis B Virus Studies (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Frédéric Delouvroy collaborates with scholars based in Sweden and Belgium. Frédéric Delouvroy's co-authors include Pierre Raboisson, Kenneth Simmen, Oliver Lenz, Tse‐I Lin, Herman de Kock, Piet Wigerinck, Katrien Vermeiren, Annick Scholliers, Bertil Samuelsson and Thierry Verbinnen and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters and Molecular Diversity.

In The Last Decade

Frédéric Delouvroy

5 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frédéric Delouvroy Sweden	4	141	97	74	50	44	5	210
Kenny Simmen Belgium	7	128 0.9×	96 1.0×	99 1.3×	99 2.0×	121 2.8×	8	327
Stacey Voss United States	6	140 1.0×	121 1.2×	86 1.2×	27 0.5×	24 0.5×	6	200
Patricia McMonagle United States	11	233 1.7×	193 2.0×	156 2.1×	35 0.7×	22 0.5×	17	294
John P. Maxwell United States	8	212 1.5×	154 1.6×	107 1.4×	127 2.5×	79 1.8×	23	409
Per-Ola Johansson Sweden	6	88 0.6×	49 0.5×	66 0.9×	109 2.2×	100 2.3×	7	280
John Tatlock United States	7	152 1.1×	86 0.9×	139 1.9×	87 1.7×	72 1.6×	10	280
Anne Ekker United States	5	119 0.8×	59 0.6×	88 1.2×	146 2.9×	67 1.5×	5	311
Monica Bisbocci Italy	7	222 1.6×	165 1.7×	148 2.0×	106 2.1×	30 0.7×	10	336
Kathy Mosure United States	6	123 0.9×	103 1.1×	65 0.9×	54 1.1×	16 0.4×	9	197
Josée Bordeleau Canada	6	55 0.4×	97 1.0×	74 1.0×	46 0.9×	113 2.6×	9	267

Countries citing papers authored by Frédéric Delouvroy

Since Specialization

Citations

This map shows the geographic impact of Frédéric Delouvroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Delouvroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Delouvroy more than expected).

Fields of papers citing papers by Frédéric Delouvroy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Delouvroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Delouvroy. The network helps show where Frédéric Delouvroy may publish in the future.

Co-authorship network of co-authors of Frédéric Delouvroy

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Delouvroy. A scholar is included among the top collaborators of Frédéric Delouvroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Delouvroy. Frédéric Delouvroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

McGowan, David C., Alex De Groot, Frederik Pauwels, et al.. (2017). Synthesis and evaluation of novel HCV replication inhibitors. Molecular Diversity. 21(2). 475–481. 2 indexed citations

2.

Lin, Tse‐I, Oliver Lenz, Gregory Fanning, et al.. (2009). In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor. Antimicrobial Agents and Chemotherapy. 53(4). 1377–1385. 142 indexed citations

3.

Raboisson, Pierre, Tse‐I Lin, Herman de Kock, et al.. (2008). Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5095–5100. 18 indexed citations

4.

Nyanguile, Origène, Frederik Pauwels, Carlo Boutton, et al.. (2008). 1,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside Inhibitors. Antimicrobial Agents and Chemotherapy. 52(12). 4420–4431. 37 indexed citations

5.

Raboisson, Pierre, Oliver Lenz, Tse‐I Lin, et al.. (2007). Evaluation of the anti-hepatitis C virus effect of novel potent, selective, and orally bioavailable JNK and VEGFR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(7). 1843–1849. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact